Medical Sensors – Defining a Pathway to Commercialization
Novel sensor technologies are under development in a variety of medical industries, to detect specific biological, chemical, or physical processes that transmit or report valuable patient data. In parallel, there is also a growing global regulatory requirement to improve the external identification...
Gespeichert in:
Veröffentlicht in: | ACS sensors 2016-10, Vol.1 (10), p.1167-1170 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Novel sensor technologies are under development in a variety of medical industries, to detect specific biological, chemical, or physical processes that transmit or report valuable patient data. In parallel, there is also a growing global regulatory requirement to improve the external identification of implantable medical devices, e.g., manufacturer, device, and procedure-related information. Sensor developers and manufacturers need to define a concise regulatory and commercialization plan that identifies the challenges, risks, costs, and timelines of bringing such technologies to the market, well in advance of finalizing initial design requirements. |
---|---|
ISSN: | 2379-3694 2379-3694 |
DOI: | 10.1021/acssensors.6b00553 |